Quadrant Capital Group’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
Quadrant Capital Group's TWST Position: Q2 2026 in Review
Quadrant Capital Group sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 128 shares — an estimated $6.08K sold.
Quadrant Capital Group first reported a position in TWST in Q1 2021 and held it in 20 quarters. The position peaked at $12K in Q3 2022. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- Quadrant Capital Group reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 128 Twist Bioscience shares in Q2 2026, an estimated $6.08K.
- Quadrant Capital Group first reported a position in Twist Bioscience in Q1 2021 and held it in 20 quarters.
- Quadrant Capital Group's Twist Bioscience position peaked at $12K in Q3 2022.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.